Vortioxetine

Download image
Mode of action
Vortioxetine
Transporter zone
Important for clinical effects
Enzyme zone
No interaction
Receptor zone
Ion channel zone
No interaction
References
  1. Bang-Andersen B et al. J Med Chem 2011; 54, 3206-3221.
  2. Mahableshwarkar AR et al. Neuropsychopharmacology 2015; 40(8):2025-37.
  3. Sanchez C et al. Pharmacol Ther. 2015; 145:43-57.

For more detailed explanation of the principles of the VM Library

Please notice that Caution should be applied when extrapolating animal data to humans.

Detailed and Approved Information on the clinical use of the compounds can be found at the homepage of EMA or at Martindale.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.